Susquehanna Fundamental Investments, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $82,302 - $145,514	-42,424 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $72,990 - $145,606	-37,431 Reduced 46.87%	42,424 $89,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $54,738 - $88,500	-14,367 Reduced 15.25%	79,855 $315,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $265,066 - $419,557	78,422 Added 496.34%	94,222 $453,000
Q2 2021 Aug 11, 2021	BUY	$4.12 - $5.87 $65,096 - $92,746	15,800 New	15,800 $73,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.